Shenzhen TargetRx, Inc.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Holding, Joint Venture
- Established
- 2014-08-04
- Employees
- 1
- Market Cap
- -
TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Shenzhen TargetRx, Inc.
- Target Recruit Count
- 198
- Registration Number
- NCT05441956
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients
- First Posted Date
- 2022-06-28
- Last Posted Date
- 2024-02-29
- Lead Sponsor
- Shenzhen TargetRx, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT05434312
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath